Disruption of the blood brain barrier by brain metastases of triple‐negative and basal‐type breast cancer but not <i>HER2/neu</i>‐positive breast cancer
2009 · Cancer · 128 citations
https://doi.org/10.1002/cncr.24735
Y
Yutaka Hatanaka
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
237
Papers
3.5K
Citations
33
h-index
90
i10-index
Yutaka Hatanaka is an academic researcher from Hokkaido University. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics. The author has an h-index of 33, co-authored 202 publications.
ORCID: 0000-0003-3128-1477Papers by this author
worksp53 accumulation is a strong predictor of recurrence in estrogen receptor‐positive breast cancer patients treated with aromatase inhibitors
2013 · Cancer Science · 76 citations
https://doi.org/10.1111/cas.12302
Quantitative immunohistochemical evaluation of HER2/<i>neu</i> expression with HercepTest<sup>TM</sup> in breast carcinoma by image analysis
2001 · Pathology International · 59 citations
https://doi.org/10.1046/j.1440-1827.2001.01162.x
Fluorescent imaging of superficial head and neck squamous cell carcinoma using a γ-glutamyltranspeptidase-activated targeting agent: a pilot study
2016 · BMC Cancer · 35 citations
https://doi.org/10.1186/s12885-016-2421-z
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
2014 · BMC Cancer · 34 citations
https://doi.org/10.1186/1471-2407-14-687
Desmoplastic small round cell tumor of the parotid gland-report of a rare case and a review of the literature
2019 · Diagnostic Pathology · 30 citations
https://doi.org/10.1186/s13000-019-0825-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat